The Bank of N.T. Butterfield & Son Limited provides a range of community, commercial, and private banking services to individuals and small to medium-sized businesses. The company accepts retail and corporate checking, savings, term, and interest bearing and non-interest bearing deposits. Its lending portfolio includes residential mortgage lending, automobile lending, consumer financing, credit cards, overdraft facilities, commercial real estate lending, and commercial and industrial loans, as well as overdraft facilities to commercial and corporate customers. It also offers investment products and services; and cash and liquidity management, foreign exchange, custody administration, and settlement services. In addition, the company provides personal and property/auto insurance products; letters of credit; and cash management, payroll, remote banking, money market, advisory, brokerage, trust, estate, company management, wealth management, and fiduciary services. Further, it offers debit and credit cards; automated teller machines; and personal and business deposit, merchant acquiring, residential and commercial mortgages, and mobile and internet banking services. The company operates through offices in the Cayman Islands, Guernsey, Jersey, the United Kingdom, The Bahamas, Switzerland, Singapore, Mauritius, and Canada. It also operates in Bermuda and the Cayman Islands. The company was founded in 1784 and is headquartered in Hamilton, Bermuda.

Bank of N.T. Butterfield & Son Limited (The) Voting

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alpha Cognition Inc (ACOG), Insmed (INSM) and Connec...

Analysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG), Insmed (INSM) and Connect Biopharma Holdings (CNTB)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNY), Milestone Pharmaceuticals (MIST) and...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (SNY), Milestone Pharmaceuticals (MIST) and Connect Biopharma Holdings (CNTB)

Current Quarter	$1.39	Next Quarter	$1.39
Current Year	$5.94	Next Year	$6.7
QoQ Growth	+0.0%	YoY Growth	+12.8%
3Y EPS CAGR	N/A	Target Price	$57.33
Consensus	Buy	Upside	+1.5%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NTB	$56.51	0.00%	140.55K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NTB	$56.51	0%	140.55K
3
4
5
6

NTB

NTB

EPS Estimates Overview

Quarterly EPS Estimates

Revenue Analysis

Get Bank of N.T. Butterfield & Son Limited (The) Voting Data in Excel

Get Bank of N.T. Butterfield & Son Limited (The) Voting Data in Excel